by 
The global Digital Breast Tomosynthesis Equipment Market is estimated to be valued at US$ 2,400.6 Mn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Digital breast tomosynthesis equipment uses low-dose x-rays and advanced computational systems to generate 3D images of the breast. It helps in detection of breast cancer at an early stage by identifying subtle clusters of microcalcifications and small irregular masses that may be obscured on conventional 2D digital mammography. The tomosynthesis 3D images provide clear visibility of the breast tissue for radiologists to accurately diagnose cancer. It results in fewer tissue biopsies and improved cancer detection rates compared to regular mammograms.
Market key trends:
One of the major trends in the digital breast tomosynthesis equipment market is increasing adoption rates across hospitals and diagnostic centers. According to the American College of Radiology, between 2010 to 2019 the use of tomosynthesis systems by U.S. facilities increased from 3% to 72%. Rising incidences of breast cancer worldwide along with growing awareness about early detection are expected to further boost adoption. Technological advancements including improved visualization of lesions, faster imaging speed, automated whole breast ultrasound for screening are also fueling the market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate due to the high capital investment required to enter the market. However, the increasing demand has encouraged small and medium enterprises to enter the market.
Bargaining power of buyers: The bargaining power of buyers in the digital breast tomosynthesis equipment market is moderate since the introduction of technologically advanced equipment provides options to the healthcare providers.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as the industry comprises few major players. However, the availability of substitutes maintains a balance in pricing and supply.
Threat of new substitutes: The threat of substitution is moderate as there are limited substitutes for DBT systems. However, new and advanced breast screening techniques may pose a potential threat.
Competitive rivalry: Intense as major players are engaged in new product launches and partnerships to gain higher market shares.
Key Takeaways
The global digital breast tomosynthesis equipment market is expected to witness high growth, exhibiting 15% CAGR over the forecast period, due to increasing penetration of advanced breast cancer screening modalities.
Regional analysis: North America dominates the global digital breast tomosynthesis equipment market owing to increased breast cancer awareness, growing demand for advanced screening technologies, and supportive government initiatives in the region. Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period. Growing healthcare investments and infrastructure, increasing women’s health concerns, and expanding medical tourism industry are expected to propel the regional market.
Key players: Key players operating in the digital breast tomosynthesis equipment market growth include Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation. Hologic dominates the global market with the widest range of DBT products. GE Healthcare and Siemens Healthineers follow Hologic in terms of revenue generation.
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
